Noevir Holdings Co., Ltd. (TYO:4928)

Market Cap	153.19B +4.8%
Revenue (ttm)	63.39B -1.0%
Net Income	8.38B +5.6%
EPS	245.28 +5.6%
Shares Out	34.16M
PE Ratio	18.28
Forward PE	18.82
Dividend	230.00 (5.13%)
Ex-Dividend Date	Sep 29, 2025

Volume	43,200
Average Volume	56,275
Open	4,495.00
Previous Close	4,485.00
Day's Range	4,440.00 - 4,495.00
52-Week Range	4,055.00 - 4,795.00
Beta	0.15
RSI	41.16
Earnings Date	May 13, 2026

About Noevir Holdings

Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, toiletries, medical supplies, and food products in China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company’s Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical and food business segment produces and...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1964
• Employees: 1,354
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4928

Financial Performance

In fiscal year 2025, Noevir Holdings's revenue was 64.72 billion, an increase of 1.41% compared to the previous year's 63.82 billion. Earnings were 8.03 billion, an increase of 0.75%.